(S)-2-(Benzofuran-3-yl)-N-(4-bromo-3-((3-methylpyrrolidin-1-yl)sulfonyl)phenyl)acetamide

ID: ALA4525009

PubChem CID: 155538742

Max Phase: Preclinical

Molecular Formula: C21H21BrN2O4S

Molecular Weight: 477.38

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H]1CCN(S(=O)(=O)c2cc(NC(=O)Cc3coc4ccccc34)ccc2Br)C1

Standard InChI:  InChI=1S/C21H21BrN2O4S/c1-14-8-9-24(12-14)29(26,27)20-11-16(6-7-18(20)22)23-21(25)10-15-13-28-19-5-3-2-4-17(15)19/h2-7,11,13-14H,8-10,12H2,1H3,(H,23,25)/t14-/m0/s1

Standard InChI Key:  FIYKACFXLSMUQR-AWEZNQCLSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   13.0773   -5.3078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9760   -7.8138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1454   -8.6588    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3355   -6.0859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9841   -8.6398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6753   -6.5740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5647   -8.6493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0091   -6.0985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5635   -7.8278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2661   -7.4155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2565   -5.3157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0982   -8.1065    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2782   -9.0596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6832   -7.3948    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4216   -7.4350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5050   -7.3948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8491   -7.4257    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6990   -9.0492    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    9.1401   -7.8371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7194   -7.8531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8441   -8.8496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6410   -8.6688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5524   -4.6429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4220   -8.1471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9633   -7.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7033   -6.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9025   -6.6004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3621   -7.2176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6249   -7.9880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 19  3  2  0
  2 10  2  0
 19 17  1  0
  5  2  1  0
 17  9  1  0
 10  9  1  0
  1 11  1  0
  8  6  1  0
  9  7  2  0
  5 18  1  0
  6  4  1  0
 15 19  1  0
  7 13  1  0
 12 14  2  0
 14  6  1  0
  2 14  1  0
 14 16  2  0
 13  5  2  0
 11  8  1  0
  4  1  1  0
 15 20  1  0
 20 25  1  0
 24 21  1  0
 21 22  1  0
 22 20  2  0
  1 23  1  6
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4525009

    ---

Associated Targets(Human)

ATAD2 Tchem ATPase family AAA domain-containing protein 2 (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CECR2 Tchem Cat eye syndrome critical region protein 2 (340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 477.38Molecular Weight (Monoisotopic): 476.0405AlogP: 4.41#Rotatable Bonds: 5
Polar Surface Area: 79.62Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.38CX Basic pKa: CX LogP: 3.80CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.59Np Likeness Score: -1.80

References

1. Lucas SCC, Atkinson SJ, Bamborough P, Barnett H, Chung CW, Gordon L, Mitchell DJ, Phillipou A, Prinjha RK, Sheppard RJ, Tomkinson NCO, Watson RJ, Demont EH..  (2020)  Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode.,  63  (10): [PMID:32321240] [10.1021/acs.jmedchem.0c00021]

Source